Athira Pharma reports FY24 EPS ($2.52) vs. ($3.09) last year

Cash Position. Cash, cash equivalents and investments were $51.3 million as of December 31 compared to $147.4M as of December 31, 2023. Net cash used in operations was $97.2M for the year ended December 31 compared to $100.8 M for the year ended December 31, 2023.